Search

everythinglearnresearchcommunity

for

Search:↓

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

Early hair loss may indicate future prostate issues.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

The document concludes that antiandrogenic drugs like cyproterone acetate and spironolactone are effective but not permanent treatments for skin-related androgenization in women.

People with androgenetic alopecia are more likely to have metabolic syndrome.

Androstenedione, a hormone supplement, doesn't improve muscle or performance and can cause harmful side effects.

Hirsute women with ovarian-sourced hirsutism are more likely to have irregular periods, with higher BMI and altered hormone ratios.

Cyproterone acetate is an effective treatment for women with acne, hair loss, and excessive hair growth.

The FG score is better at detecting hyperandrogenism in PCOS patients than testosterone levels or FAI, but testosterone is the recommended test for diagnosis.

Losing weight, possibly through bariatric surgery, is key to improving PCOS and hyperandrogenism symptoms in obese patients.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Men with a certain type of hair loss (vertex type AGA) may have higher levels of bad fats (triglycerides) and lower levels of good cholesterol (HDL), suggesting they could be at risk for high fat levels in the blood (hyperlipidemia).

Higher PSA levels are linked to more hirsutism in women with PCOS.

Early balding in men might be a male hormonal equivalent of polycystic ovaries syndrome in women.

A postmenopausal woman's virilization was caused by a rare ovarian tumor that was hard to detect but was successfully treated with surgery.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Metabolic syndrome is more common in people with early-onset androgenic alopecia.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

People with hair loss may have worse urinary symptoms due to an enlarged prostate.

People with androgenetic alopecia have a higher risk of metabolic syndrome.

High androgen levels cause skin issues in PCOS, affecting quality of life.

A 22-year-old woman with a rare genetic condition was successfully treated to develop normal female characteristics and regular menstruation.

These ovarian conditions cause high testosterone levels.

Higher levels of 3α-diol G are linked to more severe female pattern hair loss.

Adolescents with PCOS have higher levels of certain androgens, which are linked to hair growth but don't help diagnose PCOS better than testosterone levels.

Surgical removal of an adrenal tumor resolved hormonal issues in a young woman.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

A woman's excessive hair growth was caused by a rare benign tumor in her adrenal gland, which was successfully removed.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

A 63-year-old woman's male-like symptoms were caused by a rare testosterone-producing ovarian tumor, treated by removing her ovaries and fallopian tubes.